Loading
Latest filing published 12 Sept 2023 for Comera Life Sciences Holdings, Inc..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
David Soane appears in our data through filings on Comera Life Sciences Holdings, Inc. shares, published by SEC (Form 4). The record holds 8 filings, for trades running from 8 November 2022 to 11 September 2023.
No open-market sale appears; the market trades are 8 purchases worth €424k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2023 to date brings 7 purchases and no sales.
Half of the purchases are above €64k and half below. On 3 out of 4 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The newest entry dates from 12 September 2023: an open-market purchase of €28k, in Comera Life Sciences Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations